Add like
Add dislike
Add to saved papers

Evaluation of the toxicity of Colocasia esculenta (Aracaceae): Preliminary study of leaves infected by Phytophthora colocasiae on wistar albinos rats.

This study was designed to investigate the acute and subacute toxicity of the aqueous extract from colocasia esculenta (CE) leaves infected by Phytophthora colocsiae (PC) in rats. Toxicity of the aqueous extract was evaluated in both male and female wistar rats after a single administration (Acute model) and during 21 days (subacute model). Acute administration of the extract up to a dose 4000 mg/kg did not induce treatment related signs of toxicity or mortality of any rat tested. Therefore, LD50 was estimated to be more than 4000 mg/kg. In the subacute treatment, 3 days before the end of treatment, the male rats treated with the infected Colocasia esculenta leaves extract at doses of 800 mg/kg presented some signs of toxicity such as spiky hair, breathing, paralysis and death. Hematological analysis revealed a significant decrease (p < .05) of platelets for all doses in female rats. Biochemical investigations revealed a significant (p < .01) increase in the serum AST and HDL cholesterol at dose of 800 mg/kg in male rats. A significant decrease (p < .05) in the level of tissue creatinine at a dose of 800 mg/kg in treated female rats has also been observed. Histopathological examination revealed adverse effects on the lungs in male rats at dose of 800 mg/kg. The present findings suggest that CE infected by PC would be no major health risks at the doses tested but could affect their health at higher doses and repeated administration.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app